search
Back to results

Effectiveness of Oral Rehydration Therapy Supplemented With Zinc in the Management of Diarrhea Acute

Primary Purpose

Diarrhea, Children

Status
Unknown status
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
Zinc group
Placebo group
Sponsored by
Hospital General Naval de Alta Especialidad - Escuela Medico Naval
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diarrhea focused on measuring zinc, Duration

Eligibility Criteria

6 Months - 5 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients 6 months to 5 years old with acute diarrhea
  • Patients in their first 48 hours of onset diarrhea
  • Dehydration mild to moderate according to WHO clinical scale
  • Both sexes
  • Outpatients

Exclusion Criteria:

  • Patients with vomit (10 or more)
  • Hemodynamic Instability
  • Severe dehydration
  • Patients with heart disease
  • Patients with a history of prematurity.
  • Patients with chronic diarrhea
  • Patients whose parents refuse to provide written informed consent
  • Patients who do not comply with treatment correctly
  • Patients with suspected surgical pathology

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Placebo Comparator

    Arm Label

    Zinc group

    Placebo group

    Arm Description

    Pedialyte diarrhea oral electrolyte solution, 330 ml per day for 7 days

    Pedialyte oral electrolyte solution, 330 ml per day for 7 days

    Outcomes

    Primary Outcome Measures

    Number of bowel movements per day

    Secondary Outcome Measures

    Full Information

    First Posted
    November 9, 2015
    Last Updated
    November 9, 2015
    Sponsor
    Hospital General Naval de Alta Especialidad - Escuela Medico Naval
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02601742
    Brief Title
    Effectiveness of Oral Rehydration Therapy Supplemented With Zinc in the Management of Diarrhea Acute
    Official Title
    Effectiveness of Oral Rehydration Therapy Supplemented With Zinc in the Management of Diarrhea Acute in Mexican Children: Randomized Double-blind Study
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2015
    Overall Recruitment Status
    Unknown status
    Study Start Date
    November 2015 (undefined)
    Primary Completion Date
    January 2016 (Anticipated)
    Study Completion Date
    November 2016 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Hospital General Naval de Alta Especialidad - Escuela Medico Naval

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Acute diarrhea is the third cause of infant mortality in the world causing 15% of all deaths in children under 5 years and is responsible for nearly 1.4 million deaths in developing countries. It is considered a self-limiting disease and to this problem the recommendation of the World Health Organization (WHO) is the administration of zinc with low osmolarity oral dehydration salts for a period of 10-14 days which reduces the severity of the episode. In Mexico COFEPRIS believes the zinc salt as a food supplement and not a drug and the above problem is presented in terms of prescribing and access of this salt to the general population. In Mexico the investigators have the provision and accessibility of low osmolarity oral dehydration salts supplemented with adequate doses of zinc, which is inexpensive for the general population and offering a solution in terms of supply and management. The purpose of the study involves the evaluation Pedialyte diarrhea in the treatment of acute diarrhea in children under 5 years. The investigator sconsider the use of Pedialyte diarrhea eases their access to the population in general and it is low cost compared with the zinc salt that is sold only in specialized pharmacies under strict medical prescription Objective: Compare the duration of symptoms of acute diarrhea in the treatment with low osmolarity oral rehydration salts (Pedialyte) vs treatment of low osmolarity oral rehydration supplemented with zinc (Pedialyte diarrhea) Study Desing: Double blind, randomized, controlled.
    Detailed Description
    It will be conducted a randomized controlled double-blind in the Emergency service of the Naval General Hospital of High Specialty in the Mexico City. The period of patient inclusion in the study is October 2015 to November 2016. The patients selections is the children between 6 months and 5 years who come to the emergency room with symptoms of acute diarrhea with up to 48 hours of starting the disease, it will proceed to questioning and to assess vital signs and thorough physical examination for determine the degree of dehydration, nutritional status and rule out diagnosis of abdominal pathology emergency. Selection criteria Inclusion Patients 6 months to 5 years old with acute diarrhea Patients in their first 48 hours of onset diarrhea Dehydration mild to moderate according to WHO clinical scale Both sexes Outpatients Exclusion Patients with vomit (10 or more) Hemodynamic Instability Dehydration severe Patients with heart disease Patients with a history of prematurity. Patients with chronic diarrhea Patients whose parents refuse to provide written informed consent Patients who do not comply with treatment correctly Patients with suspected surgical pathology Elimination Patients with severe dehydration Patients in whom the parents decline for informed consent

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Diarrhea, Children
    Keywords
    zinc, Duration

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 3
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantInvestigator
    Allocation
    Randomized
    Enrollment
    350 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Zinc group
    Arm Type
    Active Comparator
    Arm Description
    Pedialyte diarrhea oral electrolyte solution, 330 ml per day for 7 days
    Arm Title
    Placebo group
    Arm Type
    Placebo Comparator
    Arm Description
    Pedialyte oral electrolyte solution, 330 ml per day for 7 days
    Intervention Type
    Other
    Intervention Name(s)
    Zinc group
    Other Intervention Name(s)
    Pedialyte diarrhea 45
    Intervention Description
    Pedialyte diarrhea oral electrolyte solution, 330 ml per day for 7 days
    Intervention Type
    Other
    Intervention Name(s)
    Placebo group
    Other Intervention Name(s)
    Pedialyte SR 45
    Intervention Description
    Pedialyte oral electrolyte solution, 330 ml per day for 7 days
    Primary Outcome Measure Information:
    Title
    Number of bowel movements per day
    Time Frame
    4 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    6 Months
    Maximum Age & Unit of Time
    5 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patients 6 months to 5 years old with acute diarrhea Patients in their first 48 hours of onset diarrhea Dehydration mild to moderate according to WHO clinical scale Both sexes Outpatients Exclusion Criteria: Patients with vomit (10 or more) Hemodynamic Instability Severe dehydration Patients with heart disease Patients with a history of prematurity. Patients with chronic diarrhea Patients whose parents refuse to provide written informed consent Patients who do not comply with treatment correctly Patients with suspected surgical pathology
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    María del Carmen Yebra Cano, Medicina
    Phone
    5585315297
    Email
    melitacar@hotmail.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    María del Carmen Yebra Cano, Medicina
    Organizational Affiliation
    Secretaria de Marina-Armada de México (Mexican Navy)
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    22579125
    Citation
    Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M, Mathers C, Black RE; Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012 Jun 9;379(9832):2151-61. doi: 10.1016/S0140-6736(12)60560-1. Epub 2012 May 11. Erratum In: Lancet. 2012 Oct 13;380(9850):1308.
    Results Reference
    background
    PubMed Identifier
    22682449
    Citation
    Gupta GR. Tackling pneumonia and diarrhoea: the deadliest diseases for the world's poorest children. Lancet. 2012 Jun 9;379(9832):2123-4. doi: 10.1016/S0140-6736(12)60907-6. No abstract available.
    Results Reference
    background
    Citation
    Aurelio Mejia y cosl., Analisis de costo beneficio de la suplementación con Zinc en el tratamiento de la diarrea aguda en niños menores de 5 años en Colombia, publicado en ESPGHAN 2015
    Results Reference
    background
    Citation
    Scrimgeour, A.; Condlin, M.; Otieno, L.; Bovill, M. Zinc intervention strategies: Costs and health benefits. In Nutrients, Dietary Supplements, and Nutriceuticals; Gerald, J.K., Watson, R.R., Preedy, V.R., Eds.; Humana Press: 201
    Results Reference
    background
    Citation
    WHO/UNICEF. Joint Statement on the Clinical Management of Acute Diarrhoea; UNICEF: 2004
    Results Reference
    background
    Citation
    Benguigui Y, Bernal C, Figueroa D, eds. Manual de Tratamiento de la Diarrea en Nin˜os. Washington, DC: Panamerican Health Organization/ Organización Panamericana de la Salud; 2008
    Results Reference
    background
    PubMed Identifier
    16740827
    Citation
    Malek MA, Curns AT, Holman RC, Fischer TK, Bresee JS, Glass RI, Steiner CA, Parashar UD. Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics. 2006 Jun;117(6):1887-92. doi: 10.1542/peds.2005-2351.
    Results Reference
    background
    PubMed Identifier
    16541699
    Citation
    Majowicz SE, McNab WB, Sockett P, Henson TS, Dore K, Edge VL, Buffett MC, Fazil A, Read S, McEwen S, Stacey D, Wilson JB. Burden and cost of gastroenteritis in a Canadian community. J Food Prot. 2006 Mar;69(3):651-9. doi: 10.4315/0362-028x-69.3.651.
    Results Reference
    background
    PubMed Identifier
    22696352
    Citation
    Lazzerini M, Ronfani L. Oral zinc for treating diarrhoea in children. Cochrane Database Syst Rev. 2012 Jun 13;(6):CD005436. doi: 10.1002/14651858.CD005436.pub3.
    Results Reference
    background
    PubMed Identifier
    25176404
    Citation
    Liberato SC, Singh G, Mulholland K. Zinc supplementation in young children: A review of the literature focusing on diarrhoea prevention and treatment. Clin Nutr. 2015 Apr;34(2):181-8. doi: 10.1016/j.clnu.2014.08.002. Epub 2014 Aug 13.
    Results Reference
    background
    Citation
    Dr Rul L. Riveron Corteguera, Fisiopatología de la diarrea aguda, Hospital pediátrico docente de la Habana 2009
    Results Reference
    background
    PubMed Identifier
    10801944
    Citation
    King JC, Shames DM, Woodhouse LR. Zinc homeostasis in humans. J Nutr. 2000 May;130(5S Suppl):1360S-6S. doi: 10.1093/jn/130.5.1360S.
    Results Reference
    background
    PubMed Identifier
    12424162
    Citation
    Baqui AH, Black RE, El Arifeen S, Yunus M, Chakraborty J, Ahmed S, Vaughan JP. Effect of zinc supplementation started during diarrhoea on morbidity and mortality in Bangladeshi children: community randomised trial. BMJ. 2002 Nov 9;325(7372):1059. doi: 10.1136/bmj.325.7372.1059.
    Results Reference
    background
    PubMed Identifier
    19876545
    Citation
    Fischer Walker CL, Fontaine O, Young MW, Black RE. Zinc and low osmolarity oral rehydration salts for diarrhoea: a renewed call to action. Bull World Health Organ. 2009 Oct;87(10):780-6. doi: 10.2471/blt.08.058990.
    Results Reference
    background
    PubMed Identifier
    20515554
    Citation
    Maggini S, Wenzlaff S, Hornig D. Essential role of vitamin C and zinc in child immunity and health. J Int Med Res. 2010 Mar-Apr;38(2):386-414. doi: 10.1177/147323001003800203.
    Results Reference
    background
    Links:
    URL
    http://www.insp.mx
    Description
    Encuesta Nacional de Salud y Nutrición 2012

    Learn more about this trial

    Effectiveness of Oral Rehydration Therapy Supplemented With Zinc in the Management of Diarrhea Acute

    We'll reach out to this number within 24 hrs